37
Inflammatory Bowel Disease Francisco A. Sylvester, MD Associate Professor of Pediatrics

Inflammatory Bowel Disease Francisco A. Sylvester, MD Associate Professor of Pediatrics

Embed Size (px)

Citation preview

Inflammatory Bowel Disease

Francisco A. Sylvester, MD

Associate Professor of Pediatrics

Goals - IBD

1. Definitions: Crohn disease – ulcerative colitis

2. Epidemiology

3. Pathophysiology - Genetics

4. Diagnosis

5. Treatment

Definitions

Crohn disease – Ulcerative colitis

Normal colon

IBD - ColonCrohn Disease Ulcerative Colitis

IBD – Disease Location

http://www.hopkins-gi.org/

Crohn disease Ulcerative colitis

Distribution of Crohn Disease

http://www.hopkins-gi.org/

Types of Crohn Disease

http://www.hopkins-gi.org/

Diagnostic Certainty

Crohn Disease Ulcerative Colitis

IBD-U

Dr. Burrill B. Crohn(1884-1983)

Epidemiology

• ~1.4 million Americans have IBD

• Mean age at diagnosis ~30 years of age

• 25% diagnosed as children

• M = F (in children with Crohn M > F)

• At CCMC: ~80-90 new patients/year

Crohn’s Disease

Ulcerative Colitis

Ulcerative Colitis(< 20 years of age)

Appendicitis - Appendectomy

Smoking

Crohn’s Disease

North-To-South Gradient

Pathophysiology

Intestinal Flora

Stomach 0-10²Duodenum 10²

Distal Ileum 107 - 108

Colon 1011 - 1012

Jejunum 10²Proximal Ileum 103

Sartor B. Gastroenterology 2008;134:577-94

“Our” DNA

90% Bacterial

10% Human

So, Why Doesn’t Everybody Have IBD?

Microbial Molecular Patterns

Muramyl dipeptide (MDP) Flagellins

Bacterial DNALipopolysaccharide (LPS)

Intestine: Steady State

~ ~~~~

~~

~Microbes

DC

Intestinal Lumen

T cells

IntactEpithelial Cell Barrier

~

MLN

TregIntestinal LP

~ ~

~

Blood

~

M Cells

“Controlled Inflammation”

~ ~~~~

~~

~ ~Microbes

Activated T cellsCytokines/Chemokines

DC

Intestinal Lumen

T cells

Damage toEpithelial Cell Barrier

Microbial Invasion

~~

~~

Intestinal Inflammation

Intestinal LP

~

http://www.randymays.com/Rugersr9-1.jpg

IBD - Genetics

• NOD2/CARD15 (chromosome 16q12)– 20-40-X risk in individuals carrying 2

abnormal alleles– Ileal Crohn disease– Stricturing – penetrating– Caucasians only

IBD - Genetics

• GWAS– ATG16L1 (Crohn disease)– IL-23R (Crohn disease and ulcerative colitis)– IL-23/Th17 pathway– > 30 novel loci

What is Changing?

Genes vs. Jeans?

Environmental Factors

• Microbial Ecology– Hygiene (Parasites)– Antibiotics– Refrigeration– Diet– Vaccines

• Tobacco

• North-to-south gradient– Vitamin D deficiency?

Pathophysiology - IBD

• Genetic predisposition

• Defective innate immunity

• Hyperactivation of effector cells

• Microbial ecology alterations

• Environmental factors

Genes Environment

Microbiota

Diagnosis

• History – Physical Exam

• Laboratory– CBC, ESR, CRP, albumin– Stool culture– Serology (antibodies to PAMPs)

• Endoscopy

• Imaging

Extraintestinal Manifestations

• Skin• Mouth• Joints• Bone

• Liver• Hypercoagulability• Kidney• Eye

•Present in ~50% patients•25% patients may have more than one•May be presenting symptom!

Growth Failure – Pediatric IBD

Complications

• Intra-abdominal sepsis (Crohn disease)

• Fecal incontinence

• Short gut syndrome (Crohn disease)

• Colon cancer

• Infertility

• Medication adverse effects (infection, cancer)

Arrow shows narrowing of the distal ileum

Arrow shows a phlegmon

Mesalamine (5-ASA)/Corticosteroids

AZA/6-MPCD: MTX

Biologics

Steroids/5_ASA

AZA/6-MPCD: MTX

Biologics

Step Up vs. Top Down

Crohn disease: Nutritional therapy

Challenges for School-Aged Children

• School absences

• Bathroom needs

• Psychosocial issues– Self-perception and self-esteem– Peer relationships

• Special diets (nutritional therapy)